Dr. Orlow serves as a Senior Advisor at Pharus, focusing on healthcare and consumer product transactions. He has over 25 years of experience in medicine, science, and finance. Dr. Orlow is Chair of the Ronald O. Perelman Department of Dermatology at New York University.
In 1995 he co-founded Anaderm, a cosmeceutical discovery company backed by Pfizer and OSI Pharmaceuticals. He participated in the sale of Anaderm to Pfizer in 2002. From 2001-2010, he rose from Advisor to Partner with Easton Capital Partners, a venture capital firm focused on healthcare and consumer products. At Easton, he was involved in the sourcing, diligence, funding, oversight and exit of investments in many healthcare companies. As an inventor, Dr. Orlow has licensed technologies to companies ranging from Pfizer to SkinMedica. An author of over 200 medical/scientific publications, he is an internationally sought-after speaker and thought leader.
A graduate of Harvard in Biochemical Sciences and with an MD-PhD in Molecular Pharmacology from Albert Einstein College of Medicine, Dr. Orlow trained in Pediatrics and Dermatology at Mt. Sinai and Yale.
Dr. Orlow is Chair of the Ronald O. Perelman Department of Dermatology at New York University. He serves as a Senior Advisor at Pharus, focusing on healthcare and consumer product transactions.